Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human SNAP29 ELISA Kit (AC3326)
Cat.#: ASET-1915
Specifications
Description Human SNAP29 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human SNAP29 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 10.25 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 125-2000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2056 Bovine Insulin ELISA Kit (AC3467) Quantitative inquiry ASET-2331 Mouse 14-3-3 zeta ELISA Kit (AC3742) Quantitative inquiry ASET-1151 Human PER1 ELISA Kit (AC2562) Quantitative inquiry ASET-2372 Human GABA A Receptor alpha 1 ELISA Kit (AC3783) Quantitative inquiry ASET-1513 Human APLNR ELISA Kit (AC2924) Quantitative inquiry ASET-1301 Human Angiotensin III ELISA Kit (AC2712) Quantitative inquiry ASET-1158 Human MLPH ELISA Kit (AC2569) Quantitative inquiry ASET-2482 Mouse ApoER2 ELISA Kit (AC3893) Quantitative inquiry ASET-2144 Rabbit Leptin ELISA Kit (AC3555) Quantitative inquiry ASET-2162 Rat AANAT ELISA Kit (AC3573) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket